Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C I Falkson

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Oncology|January 15, 1998
Prognostic factors in metastatic malignant melanoma. An analysis of 236 patients treated on clinical research studies at the Department of Medical Oncology, University of Pretoria, South Africa from 1972-1992C I Falkson, H C Falkson
Oncology|November 1, 1996
Granulocyte-macrophage-colony-stimulating factor support in patients with acute non-lymphatic leukemiaJ S Nel, C I Falkson
Oncology|July 1, 1996
Cisplatin versus cisplatin plus D-Trp-6-LHRH in the treatment of ovarian cancer: a pilot trial to investigate the effect of the addition of a GnRH analogue to cisplatinC I Falkson, H C Falkson, G Falkson
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|May 1, 1996
A phase II trial of fludarabine in patients with previously treated chronic lymphocytic leukaemiaA M Hocepied, C I Falkson, G Falkson
Current Opinion in Oncology|July 1, 1993
Combined modality treatment of gastrointestinal cancerG Falkson, C I Falkson, C B Falkson
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1992
Cyclophosphamide, doxorubicin and fluorouracil (CAF) plus depo-buserelin in the treatment of premenopausal women with metastatic breast cancerC I Falkson, H C Falkson, G Falkson
Investigational New Drugs|January 1, 1994
Phase II trial of fotemustine in patients with metastatic malignant melanomaC I Falkson, G Falkson, H C Falkson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1991
Improved results with the addition of interferon alfa-2b to dacarbazine in the treatment of patients with metastatic malignant melanomaC I Falkson, G Falkson, H C Falkson
American Journal of Clinical Oncology|August 1, 1988
High-dose medroxyprogesterone acetate plus mitomycin-C or vindesine in the treatment of advanced breast cancerC I Falkson, H C Falkson, G Falkson
Investigational New Drugs|July 1, 1989
Ifosfamide and mesna in the treatment of malignant disease mesna as urothelial protectorC I Falkson, H C Falkson, G Falkson
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Oncology|January 15, 1998
Prognostic factors in metastatic malignant melanoma. An analysis of 236 patients treated on clinical research studies at the Department of Medical Oncology, University of Pretoria, South Africa from 1972-1992C I Falkson, H C Falkson
Oncology|November 1, 1996
Granulocyte-macrophage-colony-stimulating factor support in patients with acute non-lymphatic leukemiaJ S Nel, C I Falkson
Oncology|July 1, 1996
Cisplatin versus cisplatin plus D-Trp-6-LHRH in the treatment of ovarian cancer: a pilot trial to investigate the effect of the addition of a GnRH analogue to cisplatinC I Falkson, H C Falkson, G Falkson
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|May 1, 1996
A phase II trial of fludarabine in patients with previously treated chronic lymphocytic leukaemiaA M Hocepied, C I Falkson, G Falkson
Current Opinion in Oncology|July 1, 1993
Combined modality treatment of gastrointestinal cancerG Falkson, C I Falkson, C B Falkson
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1992
Cyclophosphamide, doxorubicin and fluorouracil (CAF) plus depo-buserelin in the treatment of premenopausal women with metastatic breast cancerC I Falkson, H C Falkson, G Falkson
Investigational New Drugs|January 1, 1994
Phase II trial of fotemustine in patients with metastatic malignant melanomaC I Falkson, G Falkson, H C Falkson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1991
Improved results with the addition of interferon alfa-2b to dacarbazine in the treatment of patients with metastatic malignant melanomaC I Falkson, G Falkson, H C Falkson
American Journal of Clinical Oncology|August 1, 1988
High-dose medroxyprogesterone acetate plus mitomycin-C or vindesine in the treatment of advanced breast cancerC I Falkson, H C Falkson, G Falkson
Investigational New Drugs|July 1, 1989
Ifosfamide and mesna in the treatment of malignant disease mesna as urothelial protectorC I Falkson, H C Falkson, G Falkson
Pageof 5